Best Hospitals for Myasthenia treatment in Israel 2026

Rambam Medical Center diagnoses myasthenia gravis through rapid antibody testing and advanced neurophysiological studies. Treatment includes pyridostigmine, immunosuppressants, and biological therapies. The center specializes in robotic thymectomy for long-term remission. Specialized clinics reduce waiting times for critical immunological panels and imaging.

• Diagnostic testing: Combines AChR/MuSK antibody panels with repetitive nerve stimulation and single-fiber EMG.
• Advanced imaging: Uses mediastinal CT or MRI to screen for thymic hyperplasia or thymoma.
• Acute care: Employs plasmapheresis and intravenous immunoglobulin for patients in myasthenic crisis.
• Biological therapies: Provides access to targeted B-cell depletion treatments like rituximab for refractory cases.

Bookimed Expert Insight: While Rambam is a hub for Northern Israel, patients seeking specialized neuro-immunology often compare it with Sourasky Medical Center. Sourasky treats over 400,000 patients annually and holds JCI accreditation. Dr. Dan Kaspy at Sourasky specializes in complex immunological cases. Choosing between Haifa and Tel Aviv often depends on the urgency of robotic surgical availability.

Patient Consensus: Patients suggest requesting an EMG and antibody panel immediately to speed up the diagnosis. Many note that choosing early surgical thymectomy often leads to better results than relying solely on medication.

Surgery is a standard treatment for specific Myasthenia Gravis patients in Israel. Regional guidelines officially recommend thymectomy to improve long-term outcomes. This surgical removal of the thymus gland serves patients with thymic tumours or acetylcholine receptor antibodies. Surgeons often perform the procedure within 2 years of diagnosis.

• Clinical criteria: Doctors recommend surgery for patients aged 18 to 50 with generalised symptoms.
• Tumour management: Thymectomy is universally required if imaging detects a thymic tumour or thymoma.
• Robotic technology: Sourasky Medical Center in Tel Aviv routinely performs minimally invasive robotic surgeries.
• Patient safety: Protocols require neurological stability and fast-acting immunology treatments before entering the theatre.

Bookimed Expert Insight: Israeli medical hubs like Sourasky Medical Center manage high patient volumes with over 400,000 annual visits. Data shows senior specialists often lead the way. For example, Prof. Pnina Langevich has over 40 years of experience in immunology. This deep expertise is vital for Myasthenia Gravis. Large centres combine surgical precision with advanced autoimmune care to reduce risks during recovery.

Patient Consensus: Patients note that surgery in Israel is case-specific rather than a first-line treatment for everyone. They emphasise that high-volume specialist teams and ICU support are vital for managing neuromuscular cases safely.

Israeli hospitals manage myasthenic crises through rapid-acting immunotherapies and emergency neurointensive care. Standard protocols at centres like Sourasky Medical Center prioritise respiratory stabilisation and plasma exchange. Cases failing standard care are escalated to advanced targeted biologics under fast-track national clinical guidelines.

• Intensive care: Patients with breathing or swallowing difficulties enter specialised neurological ICUs immediately.
• Plasmapheresis: Clinicians use plasma exchange to filter harmful antibodies from the blood quickly.
• Immunoglobulin therapy: Intravenous immunoglobulins (IVIg) provide a short-term bridge to stabilise the immune system.
• Biologic escalation: Doctors utilise advanced FcRn inhibitors like Efgartigimod for severe or refractory cases.

Bookimed Expert Insight: Israeli neurology departments operate with high integration between emergency units and autoimmune specialists. Dr Pnina Langevich at Sheba Medical Center leads the National Center for Rheumatology and Autoimmune Diseases. This centralisation ensures patients in crisis bypass general wards, reaching specialised immunology experts who manage over 400,000 international cases annually across Israel’s top-ranked hospitals.

Patient Consensus: Patients emphasize treating symptoms like swallowing difficulty or a weak cough as immediate emergencies. Support in Israel focuses on rapid ICU admission while carefully avoiding medications like magnesium that can worsen muscle weakness.

Israeli medical centres diagnose Myasthenia Gravis through integrated clinical exams, antibody serology, and neurophysiological studies. JCI-accredited facilities like Sourasky Medical Center provide specialist neuro-immunology panels. This multi-step process identifies specific molecular phenotypes. Results typically guide treatment within 5 to 7 days.

• Clinical scoring: Specialists use international MG-ADL scales to baseline muscle fatigue severity.
• Tiered serology: Labs test for AChR, MuSK, and LRP4 antibodies in sequence.
• Electrophysiology: Single-fibre electromyography (SFEMG) detects micro-delays between nerves and muscle fibres.
• Chest imaging: Specialists perform CT scans to check for thymus gland enlargement.

Bookimed Expert Insight: Israeli neuro-immunology units often consolidate diagnostics into a single-week pathway. Sourasky Medical Center performs 34,000 operations annually. This high volume allows specialists like Dr Dan Kaspy to differentiate MG from mimicking rare autoimmune conditions. Patients receive a definitive subtype classification used for targeted therapy.

Patient Consensus: Patients note symptoms are often mistaken for general fatigue before a specialist evaluation. Many suggest keeping a video diary of drooping eyelids to help neurologists in Israel confirm the diagnosis.

Israel maintains standardised national protocols for treating Myasthenia Gravis (MG). These expert-developed guidelines integrate international clinical metrics. They bridge global scientific evidence with the local health system. Protocols ensure uniform diagnostic roadmaps, antibody testing, and structured medication pathways across major centres.

• Diagnostic standard: Guidelines mandate antibody panels for AChR, MuSK, and LRP4 markers.
• Clinical metrics: Physicians use MG-ADL and QMG scores to monitor progress objectively.
• Treatment pathways: Structured plans cover plasmapheresis, IVIg, and specific immunotherapy adjustments.
• Biologic escalation: Clear markers define when patients may progress to advanced biologics.
• Holistic network: National frameworks require coordinated care between neurologists and physical therapists.

Bookimed Expert Insight: Israeli protocols are notably precise regarding biologic therapy. Specialists may trigger high-efficacy biologics immediately if patients have required mechanical ventilation twice within one year. This structured approach at centres like Sourasky Medical Center ensures patients with intensive cases receive advanced medication without lengthy trial delays.

Patient Consensus: Patients find that Israeli care aligns closely with global evidence-based standards. They note that specialist neurologists manage treatment instead of GPs, with consistent access to therapies like plasmapheresis and rituximab.

Israel treats Myasthenia Gravis using a tiered medical protocol funded by the national health basket. Primary choices include pyridostigmine for symptom relief and corticosteroids for immune control. Advanced biologics like rituximab and efgartigimod are available at JCI-accredited centres like Sourasky Medical Center for refractory cases.

• First-line therapy: Pyridostigmine (Mestinon) improves muscle contraction and alleviates daily weakness.
• Immunosuppressive drugs: Specialists use prednisone, azathioprine, or mycophenolate to control autoimmune responses.
• Crisis intervention: Refractory flare-ups often require plasmapheresis or intravenous immunoglobulin (IVIg) for stabilization.
• Targeted biologics: Highly specific monoclonal antibodies like ravulizumab treat generalized AChR antibody-positive cases.

Bookimed Expert Insight: Israeli neurology units often coordinate across departments, such as rheumatology and immunology. Dr Pnina Langevich at Sheba Medical Center has over 40 years of experience in autoimmune diseases. This deep expertise ensures patients transition safely from fast-acting steroids to long-term immunosuppressants with high success rates.

Patient Consensus: Patients note that pyridostigmine helps with daily energy. They also emphasise that preparing for steroid side effects in Israel helps manage the transition to long-term immune control.

Patients must manage heat, physical overexertion, and specific medications to prevent a myasthenic crisis. High temperatures reduce nerve-to-muscle signaling stability. Israeli specialists often manage cases using plasmapheresis and immunotherapies. Pacing activities and avoiding magnesium-based supplements help maintain muscle strength and prevent sudden respiratory or swallowing difficulties.

• Heat management: Avoid saunas or hot showers to stop instant muscle draining.
• Medication safety: Check every new drug for triggers like beta-blockers or fluoroquinolones.
• Activity pacing: Break tasks into small blocks to avoid depleting acetylcholine levels.
• Infection monitoring: Promptly treat fevers to prevent immune spikes from destabilising muscles.
• Sleep hygiene: Prioritise rest since poor sleep worsens eyelid droop and limb weakness.

Bookimed Expert Insight: Israeli neurology departments, such as Sourasky Medical Center, focus heavily on personalised therapy plans. This is vital because adrenaline from stress often masks symptoms temporarily. Patients may experience a rebound flare once tension drops. Specialists like Prof Pnina Langevich, who has over 40 years of experience, emphasise tracking these hormonal and emotional shifts to prevent unexpected relapses during treatment.

Patient Consensus: Patients in Israel emphasise viewing stress as a physical trigger and advise resting before feeling depleted. They suggest sipping cold drinks during meals and using air conditioning to manage bulbar symptoms and heat-induced flares.